SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-115859
Filing Date
2019-04-24
Accepted
2019-04-24 08:30:56
Documents
9
Period of Report
2019-06-13
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d688751ddef14a.htm DEF 14A 795923
2 GRAPHIC g688751g10r71.jpg GRAPHIC 7138
3 GRAPHIC g688751g26o54.jpg GRAPHIC 37403
4 GRAPHIC g688751g29m21.jpg GRAPHIC 17938
5 GRAPHIC g688751g66k04.jpg GRAPHIC 13231
6 GRAPHIC g688751g67s39.jpg GRAPHIC 20248
7 GRAPHIC g688751g80w28.jpg GRAPHIC 20541
8 GRAPHIC g688751g87s41.jpg GRAPHIC 19027
9 GRAPHIC g688751g99k37.jpg GRAPHIC 52056
  Complete submission text file 0001193125-19-115859.txt   1050535
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-31141 | Film No.: 19762679
SIC: 2834 Pharmaceutical Preparations